MarketPeel
Insider Trading Intelligence
JC

Joseph Cappello

GNLX
CHIEF TECHNICAL OFFICER · GENELUX CORP · CIK 0001939198
FILING MIX · LIFETIME54%/46%
BUYS
14
SELLS
12
TOTAL VALUE
$124.4K
COMPANIES
1
ACTIVE SINCE
Feb 2023
HOLDINGS NOW
329,390
AVG SELL PX
$6.37
TRADE KIND
SHOWING 26 / 26
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 13 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Joseph Cappello, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+50.00%-0.99%+0.91%-1.90%-0.47%
14d6+33.33%-1.76%+1.03%-3.28%-0.97%
30d6+50.00%+2.38%+1.76%+0.62%+0.18%
60d6(1 pending)+20.00%+56.07%+4.59%+51.48%+83.62%
90d6(1 pending)+20.00%+23.29%+2.76%+20.53%+41.09%
180d6(1 pending)+60.00%+5.78%+8.10%-2.32%-33.02%
1y6(4 pending)+0.00%+40.28%+19.61%+20.68%+20.68%
2y6(6 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
GNLX · 329,390 shares · as of Jun 16, 2026
082,348164,695247,043329,390202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 14 buys / 12 sellsCOVERAGE · 14 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
GNLX
GENELUX CORP
PURCHASEGRANT
Stock grant
174,841329,390Jun 16, 2026Jun 18, 2026View →
GNLX
GENELUX CORP
SALE
Chief Technical Officer
605$2.97$1.8K154,549May 11, 2026May 12, 2026View →
GNLX
GENELUX CORP
SALE
Chief Technical Officer
906$2.42$2.2K155,154Mar 24, 2026Mar 26, 2026View →
GNLX
GENELUX CORP
SALE
Chief Technical Officer
973$5.37$5.2K156,060Nov 17, 2025Dec 11, 2025View →
GNLX
GENELUX CORP
PURCHASEGRANT
Stock grant
65,00065,000Sep 1, 2025Sep 3, 2025View →
GNLX
GENELUX CORP
PURCHASEGRANT
Stock grant
16,66616,666Sep 1, 2025Sep 3, 2025View →
GNLX
GENELUX CORP
PURCHASEGRANT
Stock grant
13,33313,333Sep 1, 2025Sep 3, 2025View →
GNLX
GENELUX CORP
SALE
Chief Technical Officer
65,0000Sep 1, 2025Sep 3, 2025View →
GNLX
GENELUX CORP
SALE
Chief Technical Officer
80,0000Sep 1, 2025Sep 3, 2025View →
GNLX
GENELUX CORP
SALE
Chief Technical Officer
16,6660Sep 1, 2025Sep 3, 2025View →
GNLX
GENELUX CORP
SALE
Chief Technical Officer
13,3330Sep 1, 2025Sep 3, 2025View →
GNLX
GENELUX CORP
PURCHASEGRANT
Stock grant
80,00080,000Sep 1, 2025Sep 3, 2025View →
GNLX
GENELUX CORP
PURCHASEGRANT
Stock grant
142,500142,500Aug 27, 2025Aug 29, 2025View →
GNLX
GENELUX CORP
PURCHASEGRANT
Stock grant
107,500159,766Aug 27, 2025Aug 29, 2025View →
GNLX
GENELUX CORP
SALE
Chief Technical Officer
1,270$3.33$4.2K158,496Aug 21, 2025Dec 11, 2025View →
GNLX
GENELUX CORP
SALE
Chief Technical Officer
1,463$3.36$4.9K157,033Aug 21, 2025Dec 11, 2025View →
GNLX
GENELUX CORP
SALE
VP, Pharmaceutical Development
4,737$2.92$13.8K52,266May 12, 2025May 13, 2025View →
GNLX
GENELUX CORP
PURCHASEGRANT
Stock grant
13,35057,003Mar 14, 2025Apr 17, 2025View →
GNLX
GENELUX CORP
PURCHASEGRANT
Stock grant
29,00043,653Dec 18, 2024Dec 20, 2024View →
GNLX
GENELUX CORP
PURCHASEGRANT
Stock grant
39,00039,000Dec 18, 2024Dec 20, 2024View →
GNLX
GENELUX CORP
SALE
VP, Pharmaceutical Development
6,300$2.34$14.7K14,653Dec 16, 2024Dec 18, 2024View →
GNLX
GENELUX CORP
PURCHASEGRANT
Stock grant
11,55720,953Mar 14, 2024Jul 8, 2024View →
GNLX
GENELUX CORP
PURCHASEGRANT
Stock grant
3,6619,396Feb 19, 2024Jul 8, 2024View →
GNLX
GENELUX CORP
PURCHASEGRANT
Stock grant
65,00065,000Sep 11, 2023Sep 12, 2023View →
GNLX
GENELUX CORP
SALE
VP, Pharmaceutical Development
3,265$23.73$77.5K5,735Aug 18, 2023Aug 22, 2023View →
GNLX
GENELUX CORP
PURCHASEGRANT
Stock grant
9,0009,000Feb 17, 2023May 2, 2023View →
Other insiders · GNLX
Loading peer insiders…
About this filer
CIK 0001939198
ROLE
Chief Technical Officer
PRIMARY
GNLX
COMPANIES
1
ACTIVE SINCE
Feb 2023
MARKETPEEL · /INSIDER/0001939198DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback